Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DETAIL: Telmisartan vs Enalapril in Diabetic Nephropathy
NCT00274118Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 1997
- Primary completion
- Jan 2004
- Modality
- Small Molecules
- Countries
- 6
01
Overview
A Phase 3 trial of telmisartan in diabetic nephropathy (DN), hypertension (HTN), sponsored by Boehringer Ingelheim. Started Jul 1997; status: completed.
02
Drugs
telmisartan
03
Conditions
diabetic nephropathy (DN)hypertension (HTN)
Beyond the preview
Go deeper on NCT00274118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00274118.